Cardiac gene therapy with PDE2A limits remodeling and arrhythmias in mouse models of heart failure induced by catecholamines https://www.biorxiv.org/content/10.1101/2023.04.17.537274v1?med=mas
Cardiac gene therapy with PDE2A limits remodeling and arrhythmias in mouse models of heart failure induced by catecholamines https://www.biorxiv.org/content/10.1101/2023.04.17.537274v1?med=mas